CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Rare Diseases (230)
Alize Pharma 3 develops therapeutic peptides for rare endocrine and metabolic diseases. Alize Pharma 3 is building a balanced portfolio of products targeting significant unmet medical needs. Its first two assets are AZP-3601, a PTH analog for hypopar...Show all
Company (Alive / Active)
Phone:
15, chemin du Saquin
Espace Europeen, Building G
Ecully, 69130
France
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compounds, compositions and uses thereof for improvement of bone disorders | Feb 05, 2018 | Mar 16, 2021 | Patent |
| Heparin-binding domain of igfbp-2 in the treatment of metabolic disorders | May 23, 2019 | Application | |
| Compounds, compositions and uses thereof for improvement of bone disorders | Feb 05, 2018 | Application |
